How much funding has iOrgan Bio raised?

iOrgan Bio has raised $2.0M in total funding, most recently a Pre-Seed round.

Who are iOrgan Bio's investors?

iOrgan Bio's investors include First Star Ventures, IndieBio, 2ndF, Alix Ventures.

When was iOrgan Bio founded?

iOrgan Bio was founded in 2024.

Where is iOrgan Bio headquartered?

iOrgan Bio is headquartered in Chapel Hill, North Carolina, United States.

What industry is iOrgan Bio in?

iOrgan Bio operates in Biotech, Healthcare.

How many employees does iOrgan Bio have?

iOrgan Bio has 11-50 employees.

iOrgan Bio

The Right Cells, Consistently, At Scale

Chapel Hill, United States · Founded 2024 · $2.0M raised

Biotech

Healthcare

Headquarters: Chapel Hill, North Carolina
Employees: 11–50
Founded: 2024
Business Model: B2B

Website: iorgan.bio
Total Funding: $2.0M
Last Round: $2.0M Pre-SeedOct 2025
Rounds: 1

About

iOrganBio (iORGAN BIO) is a Chapel Hill, North Carolina-based biotechnology company founded in 2024 that develops AI-powered cell manufacturing platforms to advance regenerative medicine and drug discovery. Its flagship CellForge platform merges AI prediction, biological sensing, and automated 3D incubation to digitize the development and manufacturing of human cells — enabling definable, reproducible, scalable, and consistent cell production for in vitro modeling, disease research, and cell therapies. The company also offers CellAtlas, a searchable database of digital profiles of in-vivo cells and tissues for benchmarking and designing cell products, and CellDiscovery for generating personalized drug discovery models for rare diseases. iOrganBio won the Best Start-Up Award at the World Orphan Drug Congress USA 2026 and is led by CEO Daniel Delubac, Ph.D. The company is backed by investors and is actively expanding its scientific advisory board and hiring in Durham, North Carolina.

Summary

iOrgan Bio is a Biotech company based in Chapel Hill, United States, founded in 2024. It has raised $2.0M in total across 1 round, most recently a $2.0M Pre-Seed round in Oct 2025. Investors include First Star Ventures, IndieBio and 2ndF.